Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royal DSM N : DSM - repurchase of shares (31 May - 4 June 2021)

06/08/2021 | 03:09am EDT

Heerlen, NL, 08 Jun 2021 09:00 CEST

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 117,895 of its own shares in the period from 31 May 2021 up to and including 4 June 2021 at an average price of €151.73. This is in accordance with the repurchase program announced on 16 March 2021, covering the commitments for the final stock dividend 2020. The consideration of this repurchase was €17.9 million.

The total number of shares repurchased under this program since 3 May 2021 to date is 686,227 shares for a total consideration of €103 million.

For more detailed information see 'Daily transaction details Share Repurchase Program announced 16 March 2021 '.

Disclaimer

Koninklijke DSM NV published this content on 08 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2021 07:08:02 UTC.


ę Publicnow 2021
All news about ROYAL DSM N.V.
07/27ROYAL DSM N : Koninklijke DSM N.V., - DSM acquires next-generation eubiotics pla..
PU
07/27ROYAL DSM N : DSM Takes Full Control Of Biotechnology Start-Up Midori USA For $6..
MT
07/27ROYAL DSM N : DSM acquires next-generation eubiotics platform start-up
PU
07/15ROYAL DSM N : DSM's global head office to move to Maastricht, the Netherlands
PU
07/13ROYAL DSM N : DSM to Exit Specialty Resins Supplier AOC
MT
07/13ROYAL DSM N : DSM informs market on the announced sale of AOC to Lone Star Funds..
PU
07/12DGAP-ADHOC : Covestro AG: Raised earnings outlook for 2021
DJ
06/23Royal DSM and Brains Bioceutical Form Exclusive Global Partnership to Unlock ..
CI
06/17ROYAL DSM N : DSM - repurchase of shares (14-15 June 2021)
PU
06/16ROYAL DSM N : to Redeem $607 Million Bond Ahead of Schedule
MT
More news
Financials
Sales 2021 8 761 M 10 345 M 10 345 M
Net income 2021 898 M 1 060 M 1 060 M
Net Debt 2021 1 130 M 1 335 M 1 335 M
P/E ratio 2021 29,7x
Yield 2021 1,55%
Capitalization 28 504 M 33 728 M 33 655 M
EV / Sales 2021 3,38x
EV / Sales 2022 3,16x
Nbr of Employees 21 313
Free-Float 91,0%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 166,90 €
Average target price 158,40 €
Spread / Average Target -5,09%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Co-Chief Executive Officer & COO
GÚraldine Matchett Co-Chief Executive Officer & CFO
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.18.54%33 728
BASF SE3.65%73 179
SHIN-ETSU CHEMICAL CO., LTD.-0.89%66 817
DUPONT DE NEMOURS, INC.4.06%39 724
EVONIK INDUSTRIES AG9.86%16 032
PIDILITE INDUSTRIES LIMITED30.22%15 867